investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Fraser Symmans

1 Collaborator(s)

Funding source

University of Texas MD Anderson Cancer Center

Jonas Bergh

Karolinska Institute

Stockholm, Sweden

Related projects

Claudia Palena

Novel Targets for Vaccine Therapy

Breast

Stuart Keith Calderwood

Extracellular Hsp70 and hyperthermia in tumor therapy

Breast

Aliccia Bollig-Fischer

The Molecular Link from Type 2 Diabetes to Breast Cancer

Breast

Jun-Lin Guan

Molecular Analysis of Signal Transduction in Cancer Development and Progression

Breast

Javed Khan

Targeting FGFR4, RAS, and PAX3-FOXO1 Gene in Rhabdomyosarcoma

Breast

Pediatric oncology or childhood cancer

Theresa A Guise

Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth

Breast

Zhihong Gong

Aberrant DNA methylation patterns of miRNAs and breast cancer racial disparities

Breast

William G Cance

Focal Adhesion Kinase - Tumor Biology and Therapeutics

Breast

Xuebiao Yao

Function of ACAP4 in CCL18-Stimulated Breast Cancer Metastasis

Breast